237 related articles for article (PubMed ID: 26337139)
1. Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF-2 pathway.
Hodson EJ; Nicholls LG; Turner PJ; Llyr R; Fielding JW; Douglas G; Ratnayaka I; Robbins PA; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
J Physiol; 2016 Mar; 594(5):1179-95. PubMed ID: 26337139
[TBL] [Abstract][Full Text] [Related]
2. Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2.
Bishop T; Talbot NP; Turner PJ; Nicholls LG; Pascual A; Hodson EJ; Douglas G; Fielding JW; Smith TG; Demetriades M; Schofield CJ; Robbins PA; Pugh CW; Buckler KJ; Ratcliffe PJ
J Physiol; 2013 Jul; 591(14):3565-77. PubMed ID: 23690557
[TBL] [Abstract][Full Text] [Related]
3. PHD2 inactivation in Type I cells drives HIF-2α-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies.
Fielding JW; Hodson EJ; Cheng X; Ferguson DJP; Eckardt L; Adam J; Lip P; Maton-Howarth M; Ratnayaka I; Pugh CW; Buckler KJ; Ratcliffe PJ; Bishop T
J Physiol; 2018 Jun; 596(18):4393-412. PubMed ID: 29917232
[TBL] [Abstract][Full Text] [Related]
4. The Endothelial Prolyl-4-Hydroxylase Domain 2/Hypoxia-Inducible Factor 2 Axis Regulates Pulmonary Artery Pressure in Mice.
Kapitsinou PP; Rajendran G; Astleford L; Michael M; Schonfeld MP; Fields T; Shay S; French JL; West J; Haase VH
Mol Cell Biol; 2016 May; 36(10):1584-94. PubMed ID: 26976644
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia Upregulates Estrogen Receptor β in Pulmonary Artery Endothelial Cells in a HIF-1α-Dependent Manner.
Frump AL; Selej M; Wood JA; Albrecht M; Yakubov B; Petrache I; Lahm T
Am J Respir Cell Mol Biol; 2018 Jul; 59(1):114-126. PubMed ID: 29394091
[TBL] [Abstract][Full Text] [Related]
6. miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.
Jiao X; Xu X; Fang Y; Zhang H; Liang M; Teng J; Ding X
Nephrology (Carlton); 2017 May; 22(5):366-373. PubMed ID: 27030384
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1alpha in melanoma cells.
Spinella F; Rosanò L; Del Duca M; Di Castro V; Nicotra MR; Natali PG; Bagnato A
PLoS One; 2010 Jun; 5(6):e11241. PubMed ID: 20574527
[TBL] [Abstract][Full Text] [Related]
8. Developmental role of PHD2 in the pathogenesis of pseudohypoxic pheochromocytoma.
Eckardt L; Prange-Barczynska M; Hodson EJ; Fielding JW; Cheng X; Lima JDCC; Kurlekar S; Douglas G; Ratcliffe PJ; Bishop T
Endocr Relat Cancer; 2021 Oct; 28(12):757-772. PubMed ID: 34658364
[TBL] [Abstract][Full Text] [Related]
9. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
10. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases.
Marxsen JH; Stengel P; Doege K; Heikkinen P; Jokilehto T; Wagner T; Jelkmann W; Jaakkola P; Metzen E
Biochem J; 2004 Aug; 381(Pt 3):761-7. PubMed ID: 15104534
[TBL] [Abstract][Full Text] [Related]
12. Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats.
Zhu Q; Hu J; Han WQ; Zhang F; Li PL; Wang Z; Li N
Am J Hypertens; 2014 Jan; 27(1):107-13. PubMed ID: 24190904
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.
Rajendran G; Schonfeld MP; Tiwari R; Huang S; Torosyan R; Fields T; Park J; Susztak K; Kapitsinou PP
J Am Soc Nephrol; 2020 Mar; 31(3):501-516. PubMed ID: 31996410
[TBL] [Abstract][Full Text] [Related]
14. miR-17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia-Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation.
Chen T; Zhou Q; Tang H; Bozkanat M; Yuan JX; Raj JU; Zhou G
J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27919930
[TBL] [Abstract][Full Text] [Related]
15. Prolyl-4-hydroxylase 2 enhances hypoxia-induced glioblastoma cell death by regulating the gene expression of hypoxia-inducible factor-α.
Sun W; Jelkmann W; Depping R
Cell Death Dis; 2014 Jul; 5(7):e1322. PubMed ID: 25010988
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase 2 deficiency limits proliferation of vascular smooth muscle cells by hypoxia-inducible factor-1{alpha}-dependent mechanisms.
Schultz K; Murthy V; Tatro JB; Beasley D
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L921-7. PubMed ID: 19304911
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells.
Han WQ; Zhu Q; Hu J; Li PL; Zhang F; Li N
Biochim Biophys Acta; 2013 Jun; 1833(6):1454-62. PubMed ID: 23466866
[TBL] [Abstract][Full Text] [Related]
18. Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.
Takei A; Ekström M; Mammadzada P; Aronsson M; Yu M; Kvanta A; André H
Sci Rep; 2017 Feb; 7():42546. PubMed ID: 28186209
[TBL] [Abstract][Full Text] [Related]
19. The novel prolyl hydroxylase-2 inhibitor caffeic acid upregulates hypoxia inducible factor and protects against hypoxia.
Guo Z; Yang Y; Li L; Zhao Q; Li Y; Liu Z; Hao L; Guo B; Diao A
Eur J Pharmacol; 2022 Nov; 934():175307. PubMed ID: 36191632
[TBL] [Abstract][Full Text] [Related]
20. Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury.
Zhao Y; Zeng H; Liu B; He X; Chen JX
Am J Physiol Renal Physiol; 2020 Aug; 319(2):F345-F357. PubMed ID: 32715763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
